Goldman Sees 30% Upside In Cigna (CI)

Goldman Sachs sees 30% upside in shares of CIGNA Corp.

, after it reported earnings. It has a Buy rating and a $45 price target on shares. In a research report sent to clients, Goldman writes, "We think a 9x forward multiple (as implied by our 6-month price target from our SOTP) is very reasonable yet still translates to almost 30% upside. More broadly, we note that if all of the core names were to trade to 10X our 2012 EPS by mid next year, CI would post over 50% upside where the average stock upside for the other core names would be just 15%." Shares of CI lost 50 cents to close at $35.16, a loss of 1.4%.